Letter Amendment to Purchase Agreement Between Baxter Healthcare Corporation and Coram, Inc. Regarding Pre-Filled Syringe and Rocephin Tier Pricing

Contract Categories: Business Finance › Modification Agreements
Summary

Baxter Healthcare Corporation and Coram, Inc. have amended their existing purchase agreement regarding the pricing tiers for pre-filled syringes and Rocephin. Due to a back-order situation, the pre-filled syringe pricing will remain at Tier 2, while Coram is now eligible for Rocephin Tier 1 pricing based on recent purchase volumes. The new Rocephin pricing will take effect on November 1, 2001. This amendment clarifies the pricing adjustments and the review process for future periods.

View More
EX-10.71 6 d95594ex10-71.txt LETTER AMENDMENT, DATED OCTOBER 25, 2000 EXHIBIT 10.71 This document contains confidential information which is not being provided to the Public. [BAXTER HEALTHCARE CORPORATION LETTERHEAD] October 25, 2001 Mr. Frank Geiger Senior Vice President Coram, Inc. 1125 17th Street, Suite 2100 Denver, CO 80202 Re: Coram / 34251865 Pre-Filled Syringe & Rocephin Tier Pricing Dear Mr. Geiger: Your Medication Delivery (formally known as I.V. Systems) Purchase Agreement with Baxter Healthcare Corporation indicates a Pre-Filled Syringe and Rocephin price tier change on each November 1 and May 1. Your Purchase Agreement states that Baxter shall review Coram's purchases of flush syringes and frozen drug products every October 1 and April 1 of each year. Based upon Coram's purchases during the six-month period, Coram's pricing shall be adjusted to the applicable tier for purchases during the next period to become effective on November 1 and May 1. The Pre-Filled Syringe Tier shall remain at the initial pricing of Tier 2 per the directive of Rose Lorella, ACT National Accounts Director, due to the back-order situation that occurred in the preceding six-month period. Based upon the total frozen sales for period April 1, 2001 through September 30, 2001 of Coram is now eligible for Rocephin Tier 1 pricing, committed volume of in sales. Rocephin Tier 1 pricing shall become effective November 1, 2001. Should you have any questions regarding this agreement, please contact Rose Lorella, ACT National Accounts Director at ###-###-####. Sincerely, /s/ HEATHER A. MARCELAIN Heather A. Marcelain Sales Contact Administrator cc: Rose Lorella Mary Maniscalco File